BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 319 filers reported holding BIONTECH SE in Q4 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,951,875 | +2.6% | 128,423 | +1.9% | 0.00% | 0.0% |
| Q2 2023 | $13,604,900 | -12.4% | 126,053 | +1.1% | 0.00% | 0.0% |
| Q1 2023 | $15,528,772 | -56.9% | 124,659 | -48.0% | 0.00% | 0.0% |
| Q4 2022 | $36,008,636 | +150.5% | 239,706 | +124.9% | 0.00% | 0.0% |
| Q3 2022 | $14,376,000 | -7.2% | 106,585 | +2.6% | 0.00% | 0.0% |
| Q2 2022 | $15,495,000 | -19.1% | 103,923 | -7.4% | 0.00% | 0.0% |
| Q1 2022 | $19,143,000 | +30.1% | 112,236 | +96.6% | 0.00% | 0.0% |
| Q4 2021 | $14,714,000 | +4.5% | 57,074 | +10.7% | 0.00% | 0.0% |
| Q3 2021 | $14,075,000 | +613.7% | 51,557 | +485.2% | 0.00% | – |
| Q2 2021 | $1,972,000 | +132.3% | 8,810 | +13.3% | 0.00% | – |
| Q1 2021 | $849,000 | +36.9% | 7,779 | +2.4% | 0.00% | – |
| Q4 2020 | $620,000 | – | 7,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |